Cerivikehl D3 Injektionen

Recall | Medicines | 31/03/2023

The distribution company Spagyra GmbH & Co. KG informed its customers on March 28, 2023, that a deviation from the specification was detected during the test for visible particles as part of the regular sampling. For this reason, the batch is being recalled. The mentioned homeopathic medicinal product is registered in Germany and was placed on the market in Austria.

Name of the medicinal product Cerivikehl D3 Injektionen
Marketing authorisation number(s) Deutschland: 14676.00.01
Marketing authorisation holder SANUM-Kehlbeck GmbH & Co. KG
Distributor Spagyra GmbH & Co. KG
Batch number(s) 22146B
Expiry date 02/28/2025
Classification of the recall1
Depth of recall Pharmacies
BASG reference number INS-640.001-4259

Further inquiry note